Mao et al. have found that downregulation of LINC00511 in CC cells increased sensitivity to paclitaxel, lowered cancer cell viability, proliferation, and induced apoptosis, resulting in CC recurrence prevention through regulating B-cell lymphoma 2 (Bcl-2), Bcl-2 Associated X-protein (Bax), metalloproteinases 2 and 9, multidrug resistance protein 1 (MRP1), P-glycoprotein, and cleaved caspase-3 [91]. This evidence concerns the gene ABCB1 and cancer.